(From the Bacteriology Department, University of Edinburgh.) Introduction.
As this paper is essentially a record of recent experimental work, an introductory survey of the now extensive literature on sulphanilamide is unnecessary, especially since several excellent and comprehensive reviews have lately appeared, notably those of Garrod (1938) and Whitby (1938) .
Like any other new therapeutic agent, which has been shown to be of value in a particular disease, and is at once tried indiscriminately in other conditions, sulphanilamide has been applied empirically to most kinds of bacterial infection.
The disadvantages of this are obvious, and the chemical has already proved itself dangerous, for if used carelessly, it results in toxic symptoms, which may even lead to fatalities. Again, clinical experience has shown that certain diseases, notably rheumatic fever, are unaffected, or may even be adversely influenced by sulphanilamide so that the attempted treatment of such diseases by sulphanilamide is not in the best interest of the patient (see Swift et al., 1938 ; Massell, 1938) .
The work carried out by the writer, therefore, has been undertaken in the hope of determining experimentally some means of testing both in vitro and in vivo the action of the chemical on various bacteria, and thus gaining more exact information of its effect on bacterial diseases in the human subject.
The experimental work may conveniently be discussed, therefore, under the headings of (a) in vitro tests and (b) animal experiments.
(a) In Vitro Tests.
For this purpose the quantitative and comparative method for testing bactericidal and bacteriostatic action, as devised by Mackie and Finkelstein (1931) Though certain workers (Colebrook, 1937) Smith, 1937 ; Hageman and Blake, 1938) .
Staphylococcal Infections.?Experimentally the drug is entirely without action, and its lack of effect is apparent in human lesions caused by this organism (see Mellon, Shinn and McBroom, 1937) .
Meningococcal Infections.?There is definite agreement by all workers that sulphanilamide is highly efficacious against the meningococcus experimentally, and clinical reports indicate that the chemical has been instrumental in reducing greatly the mortality of meningococcal meningitis, which in former times was very high (see Neal and Appelbaum, 193^) Helmholz, 1937 ; Buchtel and Cook, 1937 
